Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 11th:
CarMax Inc. (KMX - Free Report) : This retailer of used vehicles has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 0.3% over the last 60 days.
CarMax’s shares gained 7.1% over the last one month more than S&P 500’s gain of 1%. The company possesses a Momentum Score of A.
Catabasis Pharmaceuticals, Inc. : This clinical-stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.5% over the last 60 days.
Catabasis Pharmaceuticals’ shares gained 19.1% over the last one month. The company possesses a Momentum Score of A.
Ross Stores, Inc. (ROST - Free Report) : This apparel company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 2.2% over the last 60 days.
Ross Stores’ shares gained 6.8% over the last one month. The company possesses a Momentum Score of A.
Regeneron Pharmaceuticals, Inc. (REGN - Free Report) : This biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.8% over the last 60 days.
Regeneron Pharmaceuticals’ shares gained 2.5% over the last one month. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
4 Surprising Tech Stocks to Keep an Eye On
Tech stocks have been a major force behind the market’s record highs, but picking the best ones to buy can be tough. There’s a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now – before the next wave of innovations really take off.
See Stocks Now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 11th:
CarMax Inc. (KMX - Free Report) : This retailer of used vehicles has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 0.3% over the last 60 days.
CarMax’s shares gained 7.1% over the last one month more than S&P 500’s gain of 1%. The company possesses a Momentum Score of A.
Catabasis Pharmaceuticals, Inc. : This clinical-stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.5% over the last 60 days.
Catabasis Pharmaceuticals’ shares gained 19.1% over the last one month. The company possesses a Momentum Score of A.
Ross Stores, Inc. (ROST - Free Report) : This apparel company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 2.2% over the last 60 days.
Ross Stores’ shares gained 6.8% over the last one month. The company possesses a Momentum Score of A.
Regeneron Pharmaceuticals, Inc. (REGN - Free Report) : This biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.8% over the last 60 days.
Regeneron Pharmaceuticals’ shares gained 2.5% over the last one month. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
4 Surprising Tech Stocks to Keep an Eye On
Tech stocks have been a major force behind the market’s record highs, but picking the best ones to buy can be tough. There’s a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now – before the next wave of innovations really take off.
See Stocks Now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on REGN - FREE
Get the latest research report on ROST - FREE
Get the latest research report on KMX - FREE